Search clinical trials for: Cyclin-Dependent Kinase 4 (CDK4) inhibitor
Total 77015 results
-
PfizerCompletedMetastatic Breast CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Safeway FoundationRecruiting
-
Institut für Klinische Krebsforschung IKF GmbH...Recruiting
-
Istituto Scientifico Romagnolo per lo Studio e...Agenzia Italiana del FarmacoUnknownMetastatic Breast Cancer | Hormone Receptor Positive Breast Cancer | Hormone Receptor Negative Breast CancerItaly
-
Washington University School of MedicineBiovicaNot yet recruitingMetastatic Breast Cancer | Unresectable Breast CancerUnited States
-
Eli Lilly and CompanyCompletedMetastatic Castration-Resistant Prostate CancerFrance, United States, Spain
-
Hunan Cancer HospitalNot yet recruitingBreast Cancer | Endocrine Therapy | CDK4/6 Inhibitors | Subsequent Treatment
-
Mansoura UniversityRecruitingBreast Cancer Stage IVEgypt
-
Henan Cancer HospitalRecruitingDigestive System TumorsChina
-
RenJi HospitalRecruiting
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Mexico, Belgium, Korea, Republic of, Turkey, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece
-
PfizerRecruitingHealthy ParticipantsUnited States
-
Jose CarrilloEli Lilly and CompanyWithdrawnHigh Grade GliomaUnited States
-
Grupo Espanol de Investigacion en SarcomasRecruitingOsteosarcoma | Chordoma | Soft-tissue SarcomaSpain
-
Massachusetts General HospitalGlaxoSmithKlineTerminatedCoronary Artery Bypass Graft Surgery | Presence of Heparin/Platelet Factor 4 AntibodyUnited States
-
Namik Kemal UniversityNot yet recruitingCan the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 InhibitorsTurkey
-
Zhejiang Cancer HospitalRecruitingAdvanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment FailedChina
-
University of Milano BicoccaCompleted
-
McGill University Health Centre/Research Institute...RecruitingESRD | CKD Stage 4 | CKD Stage 5Canada
-
Region Örebro CountyHelsinki University Central Hospital; Hospital Clinic of Barcelona; University... and other collaboratorsRecruitingQuality of Life | Advanced Breast Cancer | Metastatic Breast Cancer | Toxicity | Older PatientsSweden, Finland, Greece, Italy, Norway, Spain
-
Eli Lilly and CompanyCompletedMetastatic Cancer | Advanced CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
Calithera Biosciences, IncCompletedNSCLC | Solid Tumors | KRAS Gene Mutation | CRCUnited States
-
Shanghai Pharma Biotherapeutics USA Inc.RecruitingLiposarcoma, DedifferentiatedUnited States
-
University of Alabama at BirminghamTerminatedHead and Neck CancerUnited States
-
American Society of Clinical OncologyPatient-Centered Outcomes Research InstituteNot yet recruitingMetastatic Breast Cancer
-
Maastricht Radiation OncologyMaastricht University Medical CenterWithdrawnStage 4 Cancer
-
Taixing People's HospitalRecruiting
-
Erasmus Medical CenterActive, not recruiting
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
PfizerCompletedHealthy ParticipantsNetherlands
-
California Institute of Renal ResearchRecruitingCKD Stage 4 | CKD Stage 5 | CKD Stage 3United States
-
Hoffmann-La RocheRecruitingEstrogen Receptor-Positive, HER2-Negative Advanced Breast CancerBelgium, Korea, Republic of, United States, Canada, China, Italy, France, Brazil, Australia, Argentina, Hong Kong, Portugal, Spain, Taiwan, Costa Rica, Israel, Thailand, Germany, New Zealand, Poland, Chile, Colombia, Guatemala, Hungary, Indi...
-
G1 Therapeutics, Inc.TerminatedSmall Cell Lung CancerUnited States, Croatia, Belgium, Slovakia, Bosnia and Herzegovina, North Macedonia, Serbia, Slovenia
-
European Organisation for Research and Treatment...Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaboratorsActive, not recruitingBreast Cancer Stage II | Breast Cancer Stage IIISpain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
-
University of Illinois at ChicagoAbbottCompleted
-
Institute of Cancer Research, United KingdomRecruitingBreast Cancer FemaleUnited Kingdom
-
Université Paris-SudCompletedOne-day Training Simulation With 4 Immersive ScenariosFrance
-
Azienda Sanitaria Locale 4, TeramoUnknown
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSafety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer (RADIOCOM)Chemotherapeutic Toxicity | Radiotherapy; Complications | PARP Inhibitor | Immune Checkpoint Inhibitor | Trastuzumab | Breast Cancer, Familial Male | CDK4/6 Inhibitor | PertuzumabChina
-
Yonsei UniversityActive, not recruiting
-
University Hospital HeidelbergCompleted
-
Azienda USL 4 PratoCompletedBreast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Gastrointestinal CancerItaly
-
Mahmoud Hussein BahrActive, not recruitingComparing the Analgesic Outcome by ( 4 in 1 Block ) & ( Adductor Canal Block )Egypt
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Completed
-
Assiut UniversityCompletedMyopia ≤ -6 Diopters or Myopic Astigmatism ≤ -4 DioptersEgypt
-
Dartmouth-Hitchcock Medical CenterRecruitingAdvanced Breast CancerUnited States
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerItaly
-
University of Texas Southwestern Medical CenterActive, not recruitingAbemaciclib w/Bevacizumab in Recurrent GBM Pts w/Loss of CDKN2A/B or Gain or Amplification of CDK4/6Glioblastoma | Brain Tumor | GBM | Brain Tumor, RecurrentUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedCCND1 Gene Amplification | CCND2 Gene Amplification | CCND3 Gene Amplification | CDK4 Gene Amplification | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7United States